-

NVEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NV5 Global, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NV5 Global, Inc. (NASDAQ: NVEE) to Acuren Corporation is fair to NV5 shareholders. Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren common stock at closing.

Halper Sadeh encourages NV5 shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether NV5 and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for NV5 shareholders; (2) determine whether Acuren is underpaying for NV5; and (3) disclose all material information necessary for NV5 shareholders to adequately assess and value the merger consideration.

On behalf of NV5 shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLC

NASDAQ:NVEE

Release Versions

Contacts

Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLC

AVO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Mission Produce, Inc. is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Mission Produce, Inc. (NASDAQ: AVO) and Calavo Growers, Inc. is fair to Mission shareholders. Upon completion of the proposed transaction, Mission shareholders are expected to own approximately 80.3% of the combined company. Halper Sadeh encourages Mission shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212)...

CVGW Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Calavo Growers, Inc. is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Calavo Growers, Inc. (NASDAQ: CVGW) to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission for each share of Calavo is fair to Calavo shareholders. Halper Sadeh encourages Calavo shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com....

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) breached their fiduciary duties to shareholders. If you currently own BioXcel stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about...
Back to Newsroom